vs
HOPE BANCORP INC（HOPE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是HOPE BANCORP INC的1.6倍（$219.9M vs $141.0M），HOPE BANCORP INC净利率更高（20.9% vs -1.0%，领先22.0%），HOPE BANCORP INC同比增速更快（21.0% vs 2.0%），过去两年HOPE BANCORP INC的营收复合增速更高（9.8% vs 8.0%）
希望银行（Bank of Hope）是总部位于美国洛杉矶的银行机构，前身为1980年12月30日成立的威尔希尔银行，核心服务群体为韩裔美国人社区，在当地族裔金融服务领域拥有长期的运营经验。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HOPE vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$141.0M
营收增速更快
HOPE
高出19.1%
2.0%
净利率更高
HOPE
高出22.0%
-1.0%
两年增速更快
HOPE
近两年复合增速
8.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.0M | $219.9M |
| 净利润 | $29.5M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | 20.9% | -1.0% |
| 营收同比 | 21.0% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.23 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOPEOFIX
| Q1 26 | $141.0M | — | ||
| Q4 25 | $145.8M | $219.9M | ||
| Q3 25 | $141.9M | $205.6M | ||
| Q2 25 | $94.5M | $203.1M | ||
| Q1 25 | $116.5M | $193.6M | ||
| Q4 24 | $118.0M | $215.7M | ||
| Q3 24 | $116.6M | $196.6M | ||
| Q2 24 | $116.9M | $198.6M |
净利润HOPEOFIX
| Q1 26 | $29.5M | — | ||
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $30.8M | $-22.8M | ||
| Q2 25 | $-24.8M | $-14.1M | ||
| Q1 25 | $21.1M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $24.2M | $-27.4M | ||
| Q2 24 | $25.3M | $-33.4M |
毛利率HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | 26.8% | 0.2% | ||
| Q3 25 | 25.6% | -8.3% | ||
| Q2 25 | -27.6% | -7.9% | ||
| Q1 25 | 23.9% | -25.2% | ||
| Q4 24 | 25.8% | -5.3% | ||
| Q3 24 | 27.5% | -9.6% | ||
| Q2 24 | 29.5% | -12.5% |
净利率HOPEOFIX
| Q1 26 | 20.9% | — | ||
| Q4 25 | — | -1.0% | ||
| Q3 25 | 21.7% | -11.1% | ||
| Q2 25 | -26.2% | -6.9% | ||
| Q1 25 | 18.1% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 20.7% | -13.9% | ||
| Q2 24 | 21.6% | -16.8% |
每股收益（稀释后）HOPEOFIX
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.27 | $-0.05 | ||
| Q3 25 | $0.24 | $-0.57 | ||
| Q2 25 | $-0.19 | $-0.36 | ||
| Q1 25 | $0.17 | $-1.35 | ||
| Q4 24 | $0.20 | $-0.76 | ||
| Q3 24 | $0.20 | $-0.71 | ||
| Q2 24 | $0.21 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.3B | $450.0M |
| 总资产 | $18.7B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M |
总债务HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M |
股东权益HOPEOFIX
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $450.0M | ||
| Q3 25 | $2.3B | $442.5M | ||
| Q2 25 | $2.2B | $458.3M | ||
| Q1 25 | $2.2B | $458.3M | ||
| Q4 24 | $2.1B | $503.1M | ||
| Q3 24 | $2.2B | $525.9M | ||
| Q2 24 | $2.1B | $546.0M |
总资产HOPEOFIX
| Q1 26 | $18.7B | — | ||
| Q4 25 | $18.5B | $850.6M | ||
| Q3 25 | $18.5B | $832.6M | ||
| Q2 25 | $18.5B | $837.2M | ||
| Q1 25 | $17.1B | $823.1M | ||
| Q4 24 | $17.1B | $893.3M | ||
| Q3 24 | $17.4B | $867.9M | ||
| Q2 24 | $17.4B | $882.0M |
负债/权益比HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | $164.5M | $27.7M | ||
| Q3 25 | $51.7M | $12.4M | ||
| Q2 25 | $9.4M | $11.6M | ||
| Q1 25 | $26.7M | $-18.4M | ||
| Q4 24 | $116.7M | $23.7M | ||
| Q3 24 | $63.0M | $11.7M | ||
| Q2 24 | $-25.6M | $9.0M |
自由现金流HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | $151.5M | $16.8M | ||
| Q3 25 | $47.2M | $2.5M | ||
| Q2 25 | $6.9M | $4.5M | ||
| Q1 25 | $24.0M | $-25.1M | ||
| Q4 24 | $106.9M | $15.2M | ||
| Q3 24 | $60.1M | $6.3M | ||
| Q2 24 | $-28.1M | $-360.0K |
自由现金流率HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | 103.9% | 7.6% | ||
| Q3 25 | 33.2% | 1.2% | ||
| Q2 25 | 7.3% | 2.2% | ||
| Q1 25 | 20.6% | -13.0% | ||
| Q4 24 | 90.6% | 7.0% | ||
| Q3 24 | 51.6% | 3.2% | ||
| Q2 24 | -24.0% | -0.2% |
资本支出强度HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 4.9% | ||
| Q3 25 | 3.2% | 4.8% | ||
| Q2 25 | 2.6% | 3.5% | ||
| Q1 25 | 2.3% | 3.5% | ||
| Q4 24 | 8.3% | 4.0% | ||
| Q3 24 | 2.5% | 2.7% | ||
| Q2 24 | 2.2% | 4.7% |
现金转化率HOPEOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.68× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.26× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | -1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOPE
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
